WHO ICTRP trial
Premixed glucagon/insulin solution for faster insulin absorption in Type 1…
CTIS2023-510408-32-02 · EU Clinical Trials Information System · Not Recruiting
Key facts
| Trial ID | CTIS2023-510408-32-02 |
|---|---|
| Public title | Premixed glucagon/insulin solution for faster insulin absorption in Type 1 diabetes. |
| Scientific title | Premixed glucagon/insulin solution for faster insulin absorption in Type 1 diabetes. |
| Primary sponsor | St. Olavs Hospital HF |
| Registry | EU Clinical Trials Information System |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): Yes Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): No |
| Countries | Norway |
| Conditions | Type 1 diabetes MedDRA version: 21.1Level: LLTClassification code: 10012608Term: Diabetes mellitus insulin-dependent Class: 10027433 MedDRA version: 21.1Level: LLTClassification code: 10045228Term: Type I diabetes mellitus Class… |
| Interventions | Product Name: GLUCAGON, Product Code:SUB02347MIG, Pharmaceutical Form: POWDER AND SOLVENT FOR SOLUTION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Lyumjev 100 units/mL solution for injection in vial, Product… |
| Registration date | Jun 12, 2024 |
| Target size | 30 |
| Registry page | euclinicaltrials.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: